Related Experiment Video
Updated: Mar 15, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
Unraveling cellular pathways contributing to drug-induced liver injury by dynamical modeling
Isoude A Kuijper1, Huan Yang1, Bob Van De Water1
1a Division of Toxicology, Leiden Academic Centre for Drug Research , Leiden University , Leiden , The Netherlands.
Introduction:
Drug-induced liver injury (DILI) is a significant threat to human health and a major problem in drug development. It is hard to predict due to its idiosyncratic nature and which does not show up in animal trials. Hepatic adaptive stress response pathway activation is generally observed in drug-induced liver injury. Dynamical pathway modeling has the potential to foresee adverse effects of drugs before they go in trial. Ordinary differential equation modeling can offer mechanistic insight, and allows us to study the dynamical behavior of stress pathways involved in DILI. Areas covered: This review provides an overview on the progress of the dynamical modeling of stress and death pathways pertinent to DILI, i.e. pathways relevant for oxidative stress, inflammatory stress, DNA damage, unfolded proteins, heat shock and apoptosis. We also discuss the required steps for applying such modeling to the liver. Expert opinion: Despite the strong progress made since the turn of the century, models of stress pathways have only rarely been specifically applied to describe pathway dynamics for DILI. We argue that with minor changes, in some cases only to parameter values, many of these models can be repurposed for application in DILI research. Combining both dynamical models with in vitro testing might offer novel screening methods for the harmful side-effects of drugs.
Insights
Dynamical pathway modeling can predict drug-induced liver injury (DILI) by simulating stress responses. Repurposing existing models offers a promising approach for novel drug safety screening methods.
Area of Science:
- Pharmacology and Toxicology
- Computational Biology
- Systems Biology
Background:
- Drug-induced liver injury (DILI) presents a significant challenge in drug development due to its unpredictable nature.
- Hepatic adaptive stress response pathways are consistently activated during DILI.
- Current methods, including animal trials, often fail to predict DILI accurately.
Purpose of the Study:
- To review the progress in dynamical modeling of stress and death pathways relevant to DILI.
- To explore the application of ordinary differential equation (ODE) modeling for understanding DILI mechanisms.
- To discuss the adaptation of existing pathway models for DILI research.
Main Methods:
- Review of existing literature on dynamical modeling of cellular stress pathways.
- Analysis of ODE models for pathways including oxidative stress, inflammation, DNA damage, unfolded proteins, heat shock, and apoptosis.
- Discussion on the requirements for applying these models to liver-specific DILI prediction.
Main Results:
- Significant advancements have been made in modeling cellular stress pathways since 2000.
- Models of stress pathways have been rarely applied specifically to DILI dynamics.
- Existing models can often be repurposed for DILI research with parameter adjustments.
Conclusions:
- Dynamical pathway modeling holds potential for predicting adverse drug effects before clinical trials.
- Repurposing existing stress pathway models can accelerate DILI research.
- Integrating dynamical models with in vitro testing may yield novel screening methods for drug-induced toxicity.
More Related Videos
Related Concept Videos
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Pharmacodynamic Models: Overview
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

